Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Change in Acquisitions & Divestments: 2022-2025

Historic Change in Acquisitions & Divestments for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Sep 2025 value amounting to -$425.8 million.

  • Day One Biopharmaceuticals' Change in Acquisitions & Divestments fell 458.55% to -$425.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $206.5 million, marking a year-over-year decrease of 13.07%. This contributed to the annual value of $314.5 million for FY2024, which is 45.35% down from last year.
  • Per Day One Biopharmaceuticals' latest filing, its Change in Acquisitions & Divestments stood at -$425.8 million for Q3 2025, which was down 260.80% from $264.8 million recorded in Q2 2025.
  • Day One Biopharmaceuticals' Change in Acquisitions & Divestments' 5-year high stood at $264.8 million during Q2 2025, with a 5-year trough of -$425.8 million in Q3 2025.
  • Its 3-year average for Change in Acquisitions & Divestments is $80.9 million, with a median of $136.4 million in 2024.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first surged by 759.58% in 2023, then plummeted by 458.55% in 2025.
  • Day One Biopharmaceuticals' Change in Acquisitions & Divestments (Quarterly) stood at $119.2 million in 2022, then increased by 8.70% to $129.5 million in 2023, then surged by 59.41% to $206.5 million in 2024, then plummeted by 458.55% to -$425.8 million in 2025.
  • Its Change in Acquisitions & Divestments was -$425.8 million in Q3 2025, compared to $264.8 million in Q2 2025 and $161.0 million in Q1 2025.